| Primary |
| Product Used For Unknown Indication |
34.1% |
| Hypertonic Bladder |
24.3% |
| Drug Use For Unknown Indication |
10.9% |
| Pollakiuria |
5.6% |
| Urinary Incontinence |
5.3% |
| Incontinence |
2.8% |
| Micturition Urgency |
2.5% |
| Hypertension |
2.3% |
| Nocturia |
1.7% |
| Benign Prostatic Hyperplasia |
1.7% |
| Bladder Disorder |
1.3% |
| Urge Incontinence |
1.3% |
| Blood Pressure |
1.0% |
| Stress Urinary Incontinence |
0.8% |
| Depression |
0.8% |
| Neurogenic Bladder |
0.8% |
| Pain |
0.7% |
| Blood Cholesterol |
0.7% |
| Diabetes Mellitus |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
|
| Drug Ineffective |
23.6% |
| Vision Blurred |
13.1% |
| Off Label Use |
10.9% |
| Dry Mouth |
9.8% |
| Constipation |
7.3% |
| Urinary Retention |
4.7% |
| Urinary Incontinence |
3.3% |
| Death |
2.7% |
| Wrong Technique In Drug Usage Process |
2.6% |
| Somnolence |
2.4% |
| Oedema Peripheral |
2.3% |
| Inappropriate Schedule Of Drug Administration |
2.2% |
| Pollakiuria |
2.2% |
| Nocturia |
2.2% |
| Dizziness |
2.0% |
| Urinary Tract Infection |
2.0% |
| Vomiting |
1.8% |
| Dyspepsia |
1.8% |
| Rash |
1.6% |
| Dementia |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
36.3% |
| Hypertonic Bladder |
16.7% |
| Pollakiuria |
7.2% |
| Hypertension |
5.6% |
| Micturition Urgency |
5.3% |
| Benign Prostatic Hyperplasia |
4.8% |
| Urinary Incontinence |
4.0% |
| Urge Incontinence |
2.8% |
| Incontinence |
2.0% |
| Nocturia |
2.0% |
| Drug Use For Unknown Indication |
1.8% |
| Bladder Disorder |
1.5% |
| Stress Urinary Incontinence |
1.5% |
| Urinary Tract Disorder |
1.5% |
| Pain |
1.4% |
| Depression |
1.4% |
| Myocardial Infarction |
1.2% |
| Lower Urinary Tract Symptoms |
1.0% |
| Urinary Tract Obstruction |
1.0% |
| Constipation |
1.0% |
|
| Off Label Use |
22.6% |
| Drug Ineffective |
14.6% |
| Vision Blurred |
8.8% |
| Dry Mouth |
7.2% |
| Urinary Retention |
6.0% |
| Wrong Technique In Drug Usage Process |
5.3% |
| Urinary Tract Infection |
4.1% |
| Urinary Incontinence |
3.5% |
| Inappropriate Schedule Of Drug Administration |
3.3% |
| Nocturia |
3.3% |
| Constipation |
3.1% |
| Overdose |
3.1% |
| Vomiting |
2.5% |
| Hepatic Function Abnormal |
2.1% |
| Prescribed Overdose |
1.9% |
| Weight Increased |
1.9% |
| Pollakiuria |
1.8% |
| Cardiac Failure |
1.6% |
| Dyspepsia |
1.6% |
| Oedema Peripheral |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.7% |
| Drug Use For Unknown Indication |
10.8% |
| Hypertension |
8.8% |
| Multiple Sclerosis |
7.2% |
| Pain |
4.3% |
| Depression |
4.2% |
| Rheumatoid Arthritis |
3.8% |
| Hypertonic Bladder |
3.3% |
| Osteoporosis |
3.1% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Bladder Disorder |
2.5% |
| Prophylaxis |
2.5% |
| Blood Cholesterol Increased |
2.5% |
| Asthma |
2.3% |
| Diabetes Mellitus |
2.3% |
| Anxiety |
2.2% |
| Urinary Incontinence |
2.0% |
| Insomnia |
2.0% |
| Atrial Fibrillation |
1.9% |
| Cardiac Disorder |
1.8% |
|
| Weight Increased |
12.0% |
| Urinary Tract Infection |
9.5% |
| Vomiting |
8.8% |
| Drug Ineffective |
6.6% |
| Weight Decreased |
6.4% |
| Pain |
5.7% |
| Nausea |
5.0% |
| Pneumonia |
4.8% |
| Somnolence |
4.4% |
| Death |
4.2% |
| Pain In Extremity |
4.2% |
| Tremor |
3.8% |
| Vision Blurred |
3.7% |
| White Blood Cell Count Decreased |
3.3% |
| Wheezing |
3.2% |
| Headache |
3.1% |
| Pruritus |
3.1% |
| Rash |
2.9% |
| Fatigue |
2.8% |
| Dizziness |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
21.3% |
| Hypertension |
8.8% |
| Micturition Urgency |
8.8% |
| Pollakiuria |
6.3% |
| Benign Prostatic Hyperplasia |
5.0% |
| Depression |
5.0% |
| Fibromyalgia |
5.0% |
| Hypertonic Bladder |
5.0% |
| Anxiety |
3.8% |
| Insomnia |
3.8% |
| Parkinson's Disease |
3.8% |
| Urinary Incontinence |
3.8% |
| Atrial Fibrillation |
2.5% |
| Blood Pressure |
2.5% |
| Contraception |
2.5% |
| Drug Use For Unknown Indication |
2.5% |
| Gastrointestinal Stromal Tumour |
2.5% |
| Mineral Deficiency |
2.5% |
| Musculoskeletal Pain |
2.5% |
| Schizophrenia, Paranoid Type |
2.5% |
|
| Drug Interaction |
16.7% |
| Vision Blurred |
10.0% |
| Visual Impairment |
10.0% |
| Hallucination, Visual |
6.7% |
| Palpitations |
6.7% |
| Presyncope |
6.7% |
| Electrocardiogram Qt Prolonged |
3.3% |
| Hallucination |
3.3% |
| Headache |
3.3% |
| Maternal Exposure During Pregnancy |
3.3% |
| Mental Status Changes |
3.3% |
| Migraine |
3.3% |
| Mood Altered |
3.3% |
| Off Label Use |
3.3% |
| Pain |
3.3% |
| Pregnancy On Oral Contraceptive |
3.3% |
| Psychotic Disorder |
3.3% |
| Renal Failure Acute |
3.3% |
| Somnolence |
3.3% |
|
